ClinicalTrials.Veeva

Menu

Impact of Kinesiophobia on Descending Corticospinal and Bulbospinal Projections (EchoKinésio)

U

Université de Sherbrooke

Status

Completed

Conditions

Kinesiophobia

Treatments

Behavioral: Nocebo
Behavioral: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05161832
2022-4356

Details and patient eligibility

About

Fear of movement (kinesiophobia) is a phenomenon commonly observed in people suffering from chronic pain. The aims of this project are to better understand the neurophysiological basis of this phenomenon, in particular 1) the effect of kinesiophobia (induced by nocebo intervention) on the excitability of corticospinal projections and 2) the association between kinesiophobia and top-down inhibitory mechanisms.

Full description

The study will include 44 healthy (pain-free) participants. Corticospinal measurements will be taken before and after the application of capsaicin cream (experimental pain paradigm). The investigators will manipulate kinesiophobia levels (assessed using the Tampa Kinesiophobia Scale) upward by pretending to diagnose a musculoskeletal problem in half of the participants (nocebo ultrasound), and will measure the efficacy of top-down inhibitory mechanisms using a counter-irritation paradigm (thermode and cold pressor test : the subjects will be subjected to 5 thermal stimulations, 7 mechanical stimulations and 1 water bath at 10°C of the hand) and corticospinal parameters using transcranial magnetic stimulation.

Together, these results will allow a better understanding of the mechanisms associated with a predictor of pain onset (such as kinesiophobia), by studying its interactions with endogenous pain inhibition systems and the motor system, in order to develop relevant prophylactic treatments.

Enrollment

24 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 18 years old or older
  • Healthy Volunteers
  • Capable of understanding instructions
  • Abstain from tobacco and caffeine 2 hours before data collection
  • Abstain from short-acting analgesics 6 hours before data collection

Exclusion criteria

  • A painful condition or chronic pain
  • Neurological disorders
  • Shoulder pathology
  • Skin diseases
  • Capsaicin allergy
  • Raynaud's syndrome
  • Epilepsy
  • Intracranial metallic foreign bodies, hearing aids and cochlear implants

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

24 participants in 2 patient groups

nocebo
Experimental group
Description:
Ultrasound with fake results of rotator cuff injury.
Treatment:
Behavioral: Nocebo
placebo
Active Comparator group
Description:
Ultrasound with fake results of the healthy rotator cuff.
Treatment:
Behavioral: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Guillaume Leonard, PhD; Arnaud Duport, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems